FORGOT YOUR DETAILS?

Link Healthcare Obtains Extensive Regional Rights To  Secrelux From Sanochemia Sydney/Pretoria/Singapore/Tokyo/Auckland: 14 May 2013. Specialist pharmaceutical and medical technologies business, LINK Healthcare (‘LINK’) is pleased to announce that it has signed an agreement with Sanochemia Pharmazeutika AG for regional rights to Secrelux®, a pancreatic function diagnostic.LINK has been assigned the exclusive rights to Secrelux® for Australia, New

TOP